Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$10,033,920
+$849,126 QoQ
Shares Held
382,682
-1.8% QoQ
Ownership
0.304%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 271 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. ARQT ranks #43 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in ARQT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,033,920 382,682
2026-03-31 $9,184,794 389,847
2025-12-31 $27,013,066 930,202
2025-09-30 $7,116,402 377,528
2025-06-30 $5,151,157 367,415
2025-03-31 $5,964,391 381,355
2024-12-31 $5,398,375 387,536
2024-09-30 $7,440,250 800,027
2024-06-30 $17,502,831 1,882,025
2024-03-31 $18,557,514 1,872,605
2023-12-31 $4,503,943 1,394,410
2023-09-30 $161,222 30,362
2023-06-30 $254,517 26,707
2023-03-31 $399,223 36,293
2022-12-31 $372,545 25,172
2022-09-30 $347,877 18,204
2022-06-30 $376,099 17,649
2022-03-31 $292,578 15,191
2021-12-31 $351,936 16,969
2021-09-30 $384,317 16,087
2021-06-30 $492,118 18,033
2021-03-31 $480,381 16,605
2020-12-31 $3,261,250 115,935
2020-09-30 $287,578 9,815
2020-06-30 $142,883 4,725
2020-03-31 $109,007 3,658